Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPIVASERTIB vs CAPREOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPIVASERTIB vs CAPREOMYCIN: Safety Overview

Metric CAPIVASERTIB CAPREOMYCIN
Total FAERS Reports 1,691 398
Deaths Reported 285 107
Death Rate 16.9% 26.9%
Hospitalizations 464 148
Average Patient Age 66.2 yrs 36.1 yrs
% Female Patients 94.6% 49.5%
FDA Approval Date Nov 16, 2023 Approved Prior to Jan 1, 1982
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription Discontinued